Cite
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
MLA
Pericleous, Charis, et al. “Measuring IgA Anti-Β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.” PLoS ONE, vol. 11, no. 6, June 2016, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.pone.0156407.
APA
Pericleous, C., Ferreira, I., Borghi, O., Pregnolato, F., McDonnell, T., Garza-Garcia, A., Driscoll, P., Pierangeli, S., Isenberg, D., Ioannou, Y., Giles, I., Meroni, P. L., & Rahman, A. (2016). Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. PLoS ONE, 11(6), 1–15. https://doi.org/10.1371/journal.pone.0156407
Chicago
Pericleous, Charis, Isabel Ferreira, Orietta Borghi, Francesca Pregnolato, Thomas McDonnell, Acely Garza-Garcia, Paul Driscoll, et al. 2016. “Measuring IgA Anti-Β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.” PLoS ONE 11 (6): 1–15. doi:10.1371/journal.pone.0156407.